eクリニカルソリューションの市場規模、シェア、予測、動向分析：製品別、エンドユーザー別、フェーズ別-2031年までの世界の予測

eクリニカルソリューション市場は、2024年から2031年までのCAGRが13.9%で、2031年には233億2,000万米ドルに達すると予測されます。

徹底的な2次調査と1次調査、市場シナリオの詳細な分析に基づき、主要な業界促進要因・抑制要因・課題・機会・動向について考察しています。

eクリニカルソリューション市場の成長は、主にヘルスケア＆ライフサイエンス業界で生成される大量のデータ、臨床試験数の増加、臨床研究を支援する取り組み、医学・薬学研究開発への資金提供の増加によってもたらされます。さらに、大病院チェーンによるITインフラ強化の取り組みや、精密医療に対する需要の高まりは、eClinicalソリューション市場で事業を展開するプレーヤーに成長機会をもたらすと期待されています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

• 概要
• 市場成長の要因
  • 促進要因
    • ヘルスケアおよびライフサイエンス産業から生成される大量のデータ
    • 臨床試験数の増加
    • 臨床研究を支援するイニシアチブ
  • 抑制要因
  • eクリニカルソリューションを支えるインフラのコスト高
  • 機会
    • 医学・薬学研究への資金提供の増加
    • ヘルスケア分野におけるインフラ強化の取り組み
    • 精密医療への需要の高まり
  • 課題
    • データ・セキュリティへの懸念
    • 新興諸国におけるデータシステムに関する意識の低さ
• 動向
  • 人工知能と機械学習の統合
  • 臨床試験の分散化
• 要因分析
• 規制分析
• ケーススタディ/使用事例

第5章 eクリニカルソリューション市場：製品別評価

• 概要
• 臨床データ管理システム（CDMS）
• 臨床試験管理システム（CTMS）
• 無作為化・治験薬供給管理システム
• 電子データ収集（EDC）
• 電子臨床アウトカム評価（eCOA）
• 電子患者報告アウトカム（ePRO）
• 臨床分析プラットフォーム
• 電子治験マスターファイル（eTMF）
• 臨床データ統合プラットフォーム
• 安全性ソリューション
• その他の製品タイプ

第6章 eクリニカルソリューション市場：臨床試験フェーズ別評価

• 概要
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第7章 eクリニカルソリューション市場：エンドユーザー別評価

• 概要
• 製薬・バイオ製薬企業
• 臨床研究機関
• 医療機器メーカー
• その他のエンドユーザー

第8章 eクリニカルソリューション市場：地域別評価

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • スイス
  • オランダ
  • スウェーデン
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東・アフリカ

第9章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 業界リーダー
  • 市場差別化要因
  • 先行企業
  • 新興企業
• 主要企業の市場シェア分析／市場ランキング（2023年）

第10章 企業プロファイル（事業概要、財務概要、製品ポートフォリオ、戦略的展開、SWOT分析*）。

• Dassault Systems S.E.
• Fountayn
• Merative L.P.
• eClinical Solutions LLC
• Clario（ERT and Bioclinica）
• eClinicalWorks, LLC
• IQVIA Inc.
• Parexel International（MA）Corporation
• MaxisIT Inc.
• Signant Health
• Castor
• Veeva Systems Inc.
• Oracle Corporation

（注*：SWOT分析は上位5社について記載）

第11章 付録

LIST OF TABLES

• Table 1 Global eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 2 Global Clinical Data Management Systems (CDMS) Market, by Country/Region, 2022-2031 (USD Million)
• Table 3 Global Clinical Trial Management Systems (CTMS) Market, by Country/Region, 2022-2031 (USD Million)
• Table 4 Global Randomization & Trial Supply Management Systems Market, by Country/Region, 2022-2031 (USD Million)
• Table 5 Global Electronic Data Capture (EDC) Market, by Country/Region, 2022-2031 (USD Million)
• Table 6 Global Electronic Clinical Outcome Assessments (eCOA) Market, by Country/Region, 2022-2031 (USD Million)
• Table 7 Global Electronic Patient-reported Outcomes (ePRO) Market, by Country/Region, 2022-2031 (USD Million)
• Table 8 Global Clinical Analytics Platforms Market, by Country/Region, 2022-2031 (USD Million)
• Table 9 Global Electronic Trial Master File (eTMF) Market, by Country/Region, 2022-2031 (USD Million)
• Table 10 Global Clinical Data Integration Platforms Market, by Country/Region, 2022-2031 (USD Million)
• Table 11 Global Safety Solutions Market, by Country/Region, 2022-2031 (USD Million)
• Table 12 Global Other eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
• Table 13 Global eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 14 Global eClinical Solutions Market for Phase I, by Country/Region, 2022-2031 (USD Million)
• Table 15 Global eClinical Solutions Market for Phase II, by Country/Region, 2022-2031 (USD Million)
• Table 16 Global eClinical Solutions Market for Phase III, by Country/Region, 2022-2031 (USD Million)
• Table 17 Global eClinical Solutions Market for Phase IV, by Country/Region, 2022-2031 (USD Million)
• Table 18 Global eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 19 Global eClinical Solutions Market for Pharmaceutical & Biopharmaceutical Companies, by Country/Region, 2022-2031 (USD Million)
• Table 20 Global eClinical Solutions Market for Clinical Research Organizations, by Country/Region, 2022-2031 (USD Million)
• Table 21 Global eClinical Solutions Market for Medical Device Manufacturers, by Country/Region, 2022-2031 (USD Million)
• Table 22 Global eClinical Solutions Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
• Table 23 Global eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
• Table 24 North America: eClinical Solutions Market, by Country, 2022-2031 (USD Million)
• Table 25 North America: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 26 North America: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 27 North America: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 28 U.S.: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 29 U.S.: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 30 U.S.: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 31 Canada: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 32 Canada: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 33 Canada: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 34 Europe: eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
• Table 35 Europe: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 36 Europe: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 37 Europe: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 38 Germany: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 39 Germany: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 40 Germany: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 41 France: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 42 France: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 43 France: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 44 U.K.: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 45 U.K.: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 46 U.K.: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 47 Italy: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 48 Italy: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 49 Italy: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 50 Spain: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 51 Spain: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 52 Spain: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 53 Switzerland: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 54 Switzerland: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 55 Switzerland: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 56 Sweden: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 57 Sweden: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 58 Sweden: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 59 Netherlands: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 60 Netherlands: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 61 Netherlands: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 62 Rest of Europe: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 63 Rest of Europe: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 64 Rest of Europe: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 65 Asia-Pacific: eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
• Table 66 Asia-Pacific: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 67 Asia-Pacific: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 68 Asia-Pacific: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 69 China: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 70 China: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 71 China: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 72 India: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 73 India: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 74 India: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 75 Japan: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 76 Japan: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 77 Japan: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 78 South Korea: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 79 South Korea: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 80 South Korea: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 81 Australia: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 82 Australia: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 83 Australia: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 84 Rest of Asia-Pacific: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 85 Rest of Asia-Pacific: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 86 Rest of Asia-Pacific: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 87 Latin America: eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
• Table 88 Latin America: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 89 Latin America: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 90 Latin America: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 91 Brazil: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 92 Brazil: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 93 Brazil: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 94 Mexico: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 95 Mexico: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 96 Mexico: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 97 Rest of Latin America: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 98 Rest of Latin America: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 99 Rest of Latin America: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 100 Middle East & Africa: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
• Table 101 Middle East & Africa: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
• Table 102 Middle East & Africa: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
• Table 103 Recent Developments, by Company, 2021-2024

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Secondary Sources Referenced for the Study
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
• Figure 6 Market Sizing & Growth Forecast Approach
• Figure 7 Global eClinical Solutions Market, by Product, 2024 Vs. 2031 (USD Million)
• Figure 8 Global eClinical Solutions Market, by Clinical Trials Phase, 2024 Vs. 2031 (USD Million)
• Figure 9 Global eClinical Solutions Market, by End User, 2024 Vs. 2031 (USD Million)
• Figure 10 Global eClinical Solutions Market, by Geography
• Figure 11 Impact Analysis of Market Dynamics
• Figure 12 Global eClinical Solutions Market, by Product, 2024 Vs. 2031 (USD Million)
• Figure 13 Global eClinical Solutions Market, by Clinical Trials Phase, 2024 Vs. 2031 (USD Million)
• Figure 14 Global eClinical Solutions Market, by End User, 2024 Vs. 2031 (USD Million)
• Figure 15 Global eClinical Solutions Market, by Geography, 2024 Vs. 2031 (USD Million)
• Figure 16 North America: eClinical Solutions Market Snapshot
• Figure 17 Europe: eClinical Solutions Market Snapshot
• Figure 18 Asia-Pacific: eClinical Solutions Market Snapshot
• Figure 19 Latin America: eClinical Solutions Market Snapshot
• Figure 20 Key Growth Strategies Adopted by Leading Players (2021-2024)
• Figure 21 eClinical Solutions Market: Competitive Benchmarking, by Product
• Figure 22 eClinical Solutions Market: Competitive Benchmarking, by Region
• Figure 23 eClinical Solutions Market: Competitive Dashboard
• Figure 24 Global eClinical Solutions Market Share Analysis/Market Rankings of Key Players, (2023)
• Figure 25 Dassault Systems S.E.: Financial Overview (2023)
• Figure 26 IQVIA Inc.: Financial Overview (2023)
• Figure 27 Veeva Systems Inc.: Financial Overview (2023)
• Figure 28 Oracle Corporation: Financial Overview (2023)

eClinical Solutions Market Size, Share, Forecast, & Trends Analysis by Product (CDMS, CTMS, eCOA, ePRO, eDC, eTMF, Clinical Analytics, Safety Solutions), End User (Pharmaceutical, Clinical Research Organization, Medical Device), Phase - Global Forecast to 2031

The eClinical solutions market is expected to reach $23.32 billion by 2031, at a CAGR of 13.9% from 2024 to 2031.

Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, opportunities, and trends.

The growth of the eClinical solutions market is primarily driven by the large amounts of data generated by the healthcare & life sciences industries, the growing number of clinical trials, initiatives supporting clinical research, and increasing funding for medical & pharmaceutical research & development. Moreover, IT infrastructure strengthening initiatives by large hospital chains, and the rising demand for precision medicine are expected to generate growth opportunities for the players operating in the eClinical solutions market.

Based on product, the eClinical solutions market is segmented into clinical data management systems (CDMS), clinical trial management systems (CTMS), randomization & trial supply management systems, electronic data capture (EDC), electronic clinical outcome assessments (eCOA), electronic patient-reported outcomes (ePRO), clinical analytics platforms, electronic trial master file (ETMF), clinical data integration platforms, safety solutions, and other product types. In 2024, the CDMS segment is expected to account for the largest share of 28.3% of the eClinical solutions market. The large market share of this segment is attributed to the increasing need to sort and manage the huge amount of data generated during clinical trials to gain valuable insights, and the large number of clinical trials performed each year. For instance, in 2022, 12,337 clinical trials were conducted in the Western Pacific, 13,066 in Europe, 11,935 in the Americas, 11,030 in Southeast Asia, 4,593 in the Eastern Mediterranean, and 861 in Africa (Source: World Health Organization).

Based on clinical trial phase, the eClinical solutions market is segmented into Phase I, Phase II, Phase III, and Phase IV. The Phase IV segment is expected to register the highest CAGR during the forecast period 2024-2031. The growth of this segment is attributed to the increasing importance of post-market surveillance, the growing use of real-world data and real-world evidence for the post-market surveillance of drugs, the growing number of drug approvals, and increasing R&D investments from pharmaceutical and biopharmaceutical companies.

Based on end user, the eClinical solutions market is segmented into pharmaceutical & biopharmaceutical companies, clinical research organizations, medical device manufacturers, and other end users. The clinical research organizations segment is expected to register the highest CAGR during the forecast period. The segment's growth is driven by pharmaceutical & biopharmaceutical companies' increasing outsourcing to clinical research organizations and their rising focus on R&D activities for drug discovery and development and the adoption of advanced technologies among CROs for clinical trial management.

An in-depth analysis of the geographical scenario of the eClinical solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to account for the largest share of the global eClinical solutions market in 2024, followed by Europe and Asia-Pacific. Among the U.S. and Canada included in North America, in 2024, the U.S. is expected to account for the largest share of the eClinical solutions market in North America. The large market share of the U.S. is attributed to the presence of clinical trial sponsors, the high adoption of digital solutions in the pharmaceutical industry, the large number of clinical trials conducted each year, and the high adoption of eClinical solutions ranging from data management systems to analytics due to stringent regulatory requirements set by the U.S. FDA.

Key companies operating in the global eClinical solutions market are Dassault Systems S.E. (France), Fountayn (U.S.), Merative L.P. (U.S.), eClinical Solutions LLC (U.S.), Clario (U.S.), eClinicalWorks, LLC (U.S.), IQVIA Inc. (U.S.), Parexel International (MA) Corporation (U.S.), MaxisIT Inc. (U.S.), Signant Health (U.S.), Castor (U.S.), Veeva Systems Inc. (U.S.), and Oracle Corporation (U.S.).

Scope of the Report:

eClinical Solutions Market Assessment-by Product

• Clinical Data Management Systems (CDMS)
• Clinical Trial Management Systems (CTMS)
• Randomization & Trial Supply Management Systems
• Electronic Data Capture (EDC)
• Electronic Clinical Outcome Assessments (eCOA)
• Electronic Patient-reported Outcomes (ePRO)
• Clinical Analytics Platforms
• Electronic Trial Master File (eTMF)
• Clinical Data Integration Platforms
• Safety Solutions
• Other Product Types

(Note: Other product types include regulatory information management systems, electronic consent solutions, and institutional review board systems.)

eClinical Solutions Market Assessment-by Clinical Trial Phase

• Phase I
• Phase II
• Phase III
• Phase IV

eClinical Solutions Market Assessment-by End User

• Pharmaceutical & Biopharmaceutical Companies
• Clinical Research Organizations
• Medical Device Manufacturers
• Other end Users

(Note: Other end users include consulting companies, academic & research institutes, and hospitals.)

eClinical Solutions Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Switzerland
  • Sweden
  • Netherlands
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Overview

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Data Collection & Validation Process
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing & Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Drivers
    • 4.2.1.1 Large Amounts of Data Generated from the Healthcare & Lifesciences Industries
    • 4.2.1.2. Growing Number of Clinical Trials
    • 4.2.1.3. Initiatives Supporting Clinical Research
  • 4.2.2. Restraints
  • 4.22.1. High Costs of Supporting Infrastructure for eClinical Solutions
  • 4.2.3. Opportunities
    • 4.2.3.1. Growing Funding for Medical & Pharmaceutical Research
    • 4.2.3.2. Infrastructure Strengthening Initiatives in the Healthcare Sector
    • 4.2.3.3. Growing Demand for Precision Medicine
  • 4.2.4. Challenges
    • 4.2.4.1. Data Security Concerns
    • 4.2.4.2. Low Awareness Regarding Data Systems in Developing Countries
• 4.3. Trends
  • 4.3.1. Integration of Artificial Intelligence and Machine Learning
  • 4.3.2. Decentralized Clinical Trials
• 4.4. Factors Analysis
• 4.5. Regulatory Analysis
• 4.6. Case Studies/Use Cases

5. eClinical Solutions Market Assessment-by Product

• 5.1. Overview
• 5.2. Clinical Data Management Systems (CDMS)
• 5.3. Clinical Trial Management Systems (CTMS)
• 5.4. Randomization & Trial Supply Management Systems
• 5.5. Electronic Data Capture (EDC)
• 5.6. Electronic Clinical Outcome Assessments (eCOA)
• 5.7. Electronic Patient-reported Outcomes (ePRO)
• 5.8. Clinical Analytics Platforms
• 5.9. Electronic Trial Master File (eTMF)
• 5.10. Clinical Data Integration Platforms
• 5.11. Safety Solutions
• 5.12. Other Product Types

6. eClinical Solutions Market Assessment-by Clinical Trial Phase

• 6.1. Overview
• 6.2. Phase I
• 6.3. Phase II
• 6.4. Phase III
• 6.5. Phase IV

7. eClinical Solutions Market Assessment-by End User

• 7.1. Overview
• 7.2. Pharmaceutical & Biopharmaceutical Companies
• 7.3. Clinical Research Organizations
• 7.4. Medical Device Manufacturers
• 7.5. Other End Users

8. eClinical Solutions Market Assessment-by Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Switzerland
  • 8.3.7. Netherlands
  • 8.3.8. Sweden
  • 8.3.9. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. China
  • 8.4.2. India
  • 8.4.3. Japan
  • 8.4.4. South Korea
  • 8.4.5. Australia
  • 8.4.6. Rest of Asia-Pacific
• 8.5. Latin America
• 8.6. Brazil
• 8.7. Mexico
• 8.8. Rest of Latin America
• 8.6. Middle East & Africa

9. Competition Analysis

• 9.1. Overview
• 9.2. Key Growth Strategies
• 9.3. Competitive Benchmarking
• 9.4. Competitive Dashboard
  • 9.4.1. Industry Leaders
  • 9.4.2. Market Differentiators
  • 9.4.3. Vanguards
  • 9.4.4. Emerging Companies
• 9.5. Market Share Analysis/Market Rankings of Key Players (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 10.1. Dassault Systems S.E.
• 10.2. Fountayn
• 10.3. Merative L.P.
• 10.4. eClinical Solutions LLC
• 10.5. Clario (ERT and Bioclinica)
• 10.6. eClinicalWorks, LLC
• 10.7. IQVIA Inc.
• 10.8. Parexel International (MA) Corporation
• 10.9. MaxisIT Inc.
• 10.10. Signant Health
• 10.11. Castor
• 10.12. Veeva Systems Inc.
• 10.13. Oracle Corporation

(Note*: SWOT analysis will be provided for the top 5 companies.)

11. Appendix

• 11.1. Available Customization
• 12.2. Related Reports